JEFFREY SEMLER: Open Payments
NPI 1073231031 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 17 payments from 6 companies in 2025. Trend: 2023 $162 · 2024 $454 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $182 |
| ABBVIE INC. | 4 | $67 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Alkermes, Inc. | 1 | $34 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
Products named: COBENFY, VRAYLAR, Auvelity, ARISTADA, INGREZZA, REXULTI.
Industry payments across VA — which companies pay providers there.
